• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Eitan Medical Receives FDA Clearance for Sapphire Infusion System

    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial

    RSIP Vision Announces Versatile Medical Image Segmentation Tool

    Vance Street Capital Adds Operating Partner

    Haemonetics to Acquire Cardiva for Up to $510M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    maxon

    Concise Engineering

    Creganna Medical, part of TE Connectivity

    Unicep

    MW Life Sciences
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    MW Life Sciences

    Creganna Medical, part of TE Connectivity

    Element

    Unicep
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Senseonics Forges Strategic Collaboration With Ascensia Diabetes Care

    Senseonics to focus streamlined operations on manufacturing, research and development of next generations of Eversense Systems.

    Related CONTENT
    • Heraeus Medical Components
    • DexCom Teams Up with UVA in Diabetes Research
    • Siemens Healthineers Collaborates with Novartis Pharma
    • Painless Paper Patch Glucose Level Test Uses Microneedles
    • Survey: Virtual Care Will Likely Outlast the Pandemic
    Business Wire09.29.20
    Senseonics Holdings Inc., a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, has announced the formation of a strategic partnership with Ascensia Diabetes Care (Ascensia), through a commercialization and collaboration agreement, which will make Ascensia the exclusive worldwide distributor of Senseonics’ Eversense CGM systems. The company also announced a concurrent financing agreement with PHC Holdings Corporation, the parent company of Ascensia. In addition, Senseonics also announced a financing agreement with Masters Special Situations, LLC and affiliates thereof (MSS). The financing arrangements collectively provide for a total of up to $80 million of debt and equity capital.
     
    Ascensia Diabetes Care is a global diabetes care company that is dedicated to helping people living with diabetes. It is a leader in the blood glucose monitoring (BGM) market with its CONTOUR portfolio of devices that are known for their accuracy and ease of use. Ascensia markets its BGM devices in over 125 countries across the world. The Switzerland based company is owned by PHC Holdings Corporation, a KKR portfolio company.
     
    Under the terms of the agreements, Ascensia will become the exclusive worldwide distribution partner for Senseonics’ CGM systems including Eversense, Eversense XL, and future generation products. In the United States, Ascensia will initiate marketing and sales activities in the coming months, with full responsibility and commercial ramp up expected in the first quarter of 2021. In the United States, the commercial efforts for the remainder of 2020 are intended to re-initiate marketing Eversense to drive new patient starts, as well as to prepare for the launch of the new 180-day Eversense product, if approved. In Europe, Ascensia will begin commercialization activities in select countries where Eversense XL has already launched, once any existing distribution relationships have concluded. These exclusive distribution rights are expected to last through 2025, with the exact timing dependent on factors including the launch dates for certain future generation products.
     
    Ascensia’s parent company, PHC Holdings Corporation, will also provide up to $50 million to Senseonics through (i) the purchase of $35 million in aggregate principal amount of convertible debt securities and (ii) a commitment to purchase up to an additional $15 million in convertible preferred stock, at Senseonics’ option and contingent upon U.S. Food and Drug Administration approval of the 180-day Eversense sensor in the United States. Both organizations share a vision focused on providing technology to diabetes patients around the world to lessen the burden of disease management. With strong commitments to collaboration, Senseonics will enhance focus on advancing its pipeline of long-term implantable CGM solutions, while Ascensia will be responsible for sales, marketing, market access, patient and provider onboarding, and customer support.
     
    “In line with our goal of ensuring the long-term success of Eversense in the marketplace, Ascensia has demonstrated a high level of commitment to our products that we expect will be beneficial for patients and healthcare providers for years to come,” said Francine Kaufman, M.D., chief medical officer of Senseonics.
     
    “We are thrilled to be entering into this partnership with Senseonics and strongly believe in the value of the Eversense technology. They have highly accurate and effective products on the market and a pipeline of solutions that can address the needs of people with diabetes,” said Robert Schumm, president of Ascensia Diabetes Care. “We believe that the combination of our commercial expertise and infrastructure, alongside Senseonics’ focus on product development and manufacturing, will help to get the Eversense and Eversense XL products into the hands of people with diabetes who can benefit from them. Our aim is to work together to bring these highly effective technologies to more people with diabetes, therefore providing further choice in CGM for diabetes management.”
     
    Collaboration and Commercialization Agreement
    The collaboration and commercialization agreement is designed to drive adoption of the Eversense CGM systems and future product generations by combining the strengths of the two organizations. Incentives for penetration of the market are aligned through a mutually beneficial revenue sharing agreement. Senseonics will retain all product development, branding, regulatory approval and manufacturing responsibilities.
     
    Ascensia will assume exclusive commercialization rights of Senseonics’ products for five years following U.S. availability of the 180-day Eversense product including the associated expenses, subject to extension in certain circumstances. Throughout 2020, Senseonics will lead a collaborative program for the Ascensia commercial team to receive field-based training and hands on experience supporting the current Eversense patient base as well as new patient and practice on-boarding. This creates the potential to increase the overall installed base later this year. Upon the launch of the 180-day product in the United States, if approved, Ascensia will assume full marketing, market access, sales, healthcare provider training, and frontline patient and provider support responsibilities. Ascensia has begun expanding its U.S. commercial organization and expects to be fully staffed by end of the first quarter 2021 in support of Eversense.
     
    Financing Agreements
    Senseonics has entered into an agreement to issue senior secured convertible notes to PHC Holdings Corporation in the amount of $35 million at a 9.5 percent interest rate that reduces to 8 percent if the Eversense 180-day system is approved in the United States, subject to certain conditions. The maturity date of the notes will be Oct. 31, 2024. The notes will be convertible into common stock at any time at an effective conversion premium of approximately 12.5 percent to the closing stock price on Aug. 7, 2020. Additionally, Senseonics has the option to issue convertible preferred stock to PHC Holdings Corporation in the aggregate purchase price of up to $15 million, following approval of the Eversense 180-day system in the United States, subject to stockholder approval.
     
    The capital from these financings will be used to support product development initiatives, including the regulatory efforts for the Eversense 180-day system in the United States and the development of future generation products, as well as for supporting users in the United States.
     
    In connection with the transactions described above, PHC Holdings Corporation will have the right to nominate two board members to the board and MSS will have the right to nominate one board member to the board, which board members are expected to join the board within 45 days.
     
    “We are extremely excited to be partnering with Ascensia. Ascensia is well known for their CONTOUR products used by more than 10 million patients worldwide to help manage their diabetes. We believe their global commercial infrastructure and commitment to the Eversense systems will drive market adoption while allowing Senseonics to focus on further development of our implanted technology,” said Tim Goodnow, Ph.D., president and CEO of Senseonics.
     

     
     
    Suggested For You
    Heraeus Medical Components Heraeus Medical Components
    DexCom Teams Up with UVA in Diabetes Research DexCom Teams Up with UVA in Diabetes Research
    Siemens Healthineers Collaborates with Novartis Pharma Siemens Healthineers Collaborates with Novartis Pharma
    Painless Paper Patch Glucose Level Test Uses Microneedles Painless Paper Patch Glucose Level Test Uses Microneedles
    Survey: Virtual Care Will Likely Outlast the Pandemic Survey: Virtual Care Will Likely Outlast the Pandemic
    Self-Care in Business: Four Ways to Extend the Peace of Home to the Workplace Self-Care in Business: Four Ways to Extend the Peace of Home to the Workplace
    Medtronic to Buy Smart Insulin Pen Maker Companion Medical Medtronic to Buy Smart Insulin Pen Maker Companion Medical
    Ethicon Compares Gastric Bypass Surgery to Pharmacotherapy in Treating CKD Ethicon Compares Gastric Bypass Surgery to Pharmacotherapy in Treating CKD
    Medtronic Releases MiniMed Mio Advance Infusion Set Medtronic Releases MiniMed Mio Advance Infusion Set
    Senseonics Eversense Sensor Receives MRI Conditional Approval in Europe Senseonics Eversense Sensor Receives MRI Conditional Approval in Europe
    Heraeus Collaboration Hub Begins Operations Heraeus Collaboration Hub Begins Operations
    Spectrum Plastics to Collaborate with Laser Light Technologies Spectrum Plastics to Collaborate with Laser Light Technologies
    Tandem Diabetes Acquires Sugarmate, a Diabetes Therapy Visualization App Tandem Diabetes Acquires Sugarmate, a Diabetes Therapy Visualization App
    FDA OKs Companion Medical FDA OKs Companion Medical's InPen for Pediatric Use
    One Drop Unveils New AI Predictions for CGM Users One Drop Unveils New AI Predictions for CGM Users

    Related Breaking News

    • Eitan Medical Receives FDA Clearance for Sapphire Infusion System

      Eitan Medical Receives FDA Clearance for Sapphire Infusion System

      Upgraded infusion system provides advanced performance and customization capabilities within hospital, pre-hospital and ambulatory environments.
      Eitan Medical 01.20.21

    • Materials
      Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial

      Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial

      Enables both the rate at which it degrades in the body and its mechanical properties to be controlled independently.
      University of Birmingham 01.20.21

    • Diagnostics
      RSIP Vision Announces Versatile Medical Image Segmentation Tool

      RSIP Vision Announces Versatile Medical Image Segmentation Tool

      Delivers efficient anatomical measurements and better treatment options.
      RSIP Visions 01.20.21


    • Vance Street Capital Adds Operating Partner

      Vance Street Capital Adds Operating Partner

      J. Mark King will work closely with leadership teams of portfolio companies in the medical vertical.
      Vance Street Capital LLC 01.20.21

    • Cardiovascular | Surgical
      Haemonetics to Acquire Cardiva for Up to $510M

      Haemonetics to Acquire Cardiva for Up to $510M

      Enhances penetration into the large and growing interventional cardiology and electrophysiology markets.
      PR Newswire 01.20.21

    • Cardiovascular | Surgical
      Abbott Wins Expanded Medicare Coverage for MitraClip

      Abbott Wins Expanded Medicare Coverage for MitraClip

      Includes patients with secondary (or functional) mitral regurgitation resulting from heart failure.
      Abbott Laboratories 01.20.21


    • Samsara Vision Appoints Three New Board Members

      Samsara Vision Appoints Three New Board Members

      Company recently changed its name from VisionCare Inc.
      Business Wire 01.20.21

    • Diagnostics
      Thermo Fisher Buys Mesa Biotech for $450M

      Thermo Fisher Buys Mesa Biotech for $450M

      Mesa Biotech developed, commercialized a PCR-based rapid POC testing platform for detecting infectious diseases.
      PR Newswire 01.20.21

    • AtriCure Receives FDA Clearance to Expand its Labeling for Cryo Nerve Block Therapy

      AtriCure Receives FDA Clearance to Expand its Labeling for Cryo Nerve Block Therapy

      The expansion includes adolescent patients who can benefit from cryo nerve block therapy during surgical procedures involving the chest wall.
      Business Wire 01.20.21


    • Former Covidien Executive Joins Vesper Medical Board

      Former Covidien Executive Joins Vesper Medical Board

      New board member has over 25 years in sales, marketing and operational leadership roles building innovative technology portfolios.
      Business Wire 01.20.21

    • Ra Medical Pays $2.5 Million to Settle False Claims Investigation

      Ra Medical Pays $2.5 Million to Settle False Claims Investigation

      The company did not admit any liability or wrongdoing.
      Business Wire 01.20.21

    • CHF Solutions Appoints CEO

      CHF Solutions Appoints CEO

      Nestor Jaramillo Jr succeeds John Erb.
      Globe Newswire 01.19.21


    • Surgical
      Freehand Partners with Imperial Medical Solutions

      Freehand Partners with Imperial Medical Solutions

      Supports the introduction of its surgical robots in India, Sri Lanka, Malaysia and the Caribbean.
      Freehand 01.19.21

    • Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant

      Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant

      Establishes new S code for Propel to facilitate specific coding and payment.
      Business Wire 01.19.21

    • Cardiovascular | Patient Monitoring
      Hillrom to Buy Bardy Diagnostics for $375M

      Hillrom to Buy Bardy Diagnostics for $375M

      Advances digital health offering with expansion into attractive ambulatory cardiac monitoring segment.
      PR Newswire 01.19.21


    Trending
    • Telemedicine, Regulatory Changes To Characterize Medtech Industry In 2021
    • Philips Buys Capsule Technologies In $635M Deal
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Haemonetics To Acquire Cardiva For Up To $510M
    Breaking News
    • Eitan Medical Receives FDA Clearance for Sapphire Infusion System
    • Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    • RSIP Vision Announces Versatile Medical Image Segmentation Tool
    • Vance Street Capital Adds Operating Partner
    • Haemonetics to Acquire Cardiva for Up to $510M
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Ingredient Manufacturers Discuss the E-Sports Market
    Euromonitor Names Top Ten Trends for 2021
    Study Highlights Differences Between EPA's and DHA's Effect on Sleep
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Eitan Medical Receives FDA Clearance for Sapphire Infusion System
    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    RSIP Vision Announces Versatile Medical Image Segmentation Tool
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Global Biosciences Co. Selects ValGenesis VLMS
    Eisai Appoints Chief Clinical Officer of Oncology Biz
    Nexelis Acquires GSK Vax Lab in Marburg
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Top Beauty Brands in the World—And Most Loved Fragrances
    P&G Reports Q2 Results
    A Lacquering Technique Makes Very Good Girl by Carolina Herrera Shine
    Happi

    Latest Breaking News From Happi

    Flow Launches Collagen Waters
    Associations Congratulate Biden & Harris
    David Stanko Joins JPMS
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    First Quality Launches Incognito by Prevail
    Essity Launches Reusable Underwear Product
    Honeywell Delivered 225 Million Masks in December
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    DJO Acquires Trilliant Surgical
    FDA Breakthrough Device Designation Granted to Spiderwort's Spinal Cord Technology
    Bioventus Appoints SVP of Operations
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login